Publications by authors named "Gabriel Abreu"

Claim this Profile
R
Reassessing antimalarial use in long-term SLE clinical trials - Authors' reply.
Vibeke Strand, Kenneth C Kalunian, Kai Wai Lee, Caroline Seo, Gabriel Abreu

Lancet Rheumatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial.
Vibeke Strand, Kenneth C Kalunian, Kai Wai Lee, Caroline Seo, Gabriel Abreu

Lancet Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls.
Zahi Touma, Ian N Bruce, Richard Furie, Eric Morand, Raj Tummala, Gabriel Abreu

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials.
Eric F Morand, Ronald van Vollenhoven, Richard A Furie, Kenneth C Kalunian, Susan Manzi, Gabriel Abreu

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 study.
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Gabriel Abreu

Mod Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of anifrolumab in systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 trial.
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Gabriel Abreu

Mod Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome sequences of bacteriophages SF_KL2 and SF_KL25.
Sophia Lorenz, Gabriel Abreu, Hugo Oliveira

Microbiol Resour Announc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis.
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Gabriel Abreu

Mod Rheumatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome sequence of bacteriophage Omen.
Gabriel Abreu, Edgar Garcia, Ana Oliveira, Hugo Oliveira

Microbiol Resour Announc· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine causes poor maternal care in rats with postpartum depression and leads to few behavioral and neurochemical alterations on male offspring.
Julia Zaccarelli-Magalhães, Gabriel R Abreu, André R Fukushima, Lorena P Pantaleon, Beatriz B Ribeiro

Behav Brain Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoxetine alters rat's milk properties causing impact on offspring's development.
Gabriel R Abreu, Julia Zaccarelli-Magalhães, Laís S Féba, Emily Y Penna, Julia P Silva

Toxicol Appl Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripubertal exposure of atrazine cause decrease in exploratory activity, deficits in sociability and few alterations on brain monoaminergic systems of rats.
Esther L Ricci, Julia Zaccarelli-Magalhães, Lorena P Pantaleon, Leonardo R De-Paula, Guilherme M Ribeiro, Gabriel R Abreu

Toxicol Appl Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-Hospital Aspirin Dose as a Risk Factor for Hemorrhagic Transformation in Patients Not Treated With Thrombolysis.
Joao Brainer Clares de Andrade, Jay P Mohr, Fabricio Oliveira Lima, Joao José Freitas de Carvalho, Levi Coelho Maia Barros, Gabriel Queiroz de Abreu

Neurologist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus.
Eric F Morand, Gabriel Abreu, Richard A Furie, Vera Golder, Raj Tummala

Ann Rheum Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials.
Ian N Bruce, Ronald F van Vollenhoven, Eric F Morand, Richard A Furie, Susan Manzi, Gabriel Abreu

Rheumatology (Oxford)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus.
Kenneth C Kalunian, Richard Furie, Eric F Morand, Ian N Bruce, Susan Manzi, Gabriel Abreu

Arthritis Rheumatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis.
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Gabriel Abreu

Mod Rheumatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postpartum depression in rats causes poor maternal care and neurochemical alterations on dams and long-lasting impairment in sociability on the offspring.
Julia Zaccarelli-Magalhães, Gabriel R Abreu, André R Fukushima, Lorena P Pantaleon, Beatriz B Ribeiro

Behav Brain Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal cascade of direct and indirect effects of anifrolumab on patient-reported outcomes: structural equation modelling of two Phase 3 trials.
Donald Stull, Sean O'Quinn, Betsy Williams, Stephanie Bean, Erik Schwetje, Gabriel Abreu

Rheumatology (Oxford)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Partum Depression Lactating Rat Model for Evaluating Ketamine's Safety as a Pharmacotherapeutic Treatment: Roles in Cardiac and Urinary Function.
André Rinaldi Fukushima, Pedro Enrique Navas-Suárez, Juliana Weckx Peña Muñoz, Esther Lopes Ricci, Luís Antônio Baffile Leoni, Gabriel Ramos de Abreu

J Cardiovasc Dev Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoids accumulate in mouse breast milk and differentially regulate lipid composition and lipid signaling molecules involved in infant development.
Clare T Johnson, Gabriel H Dias de Abreu, Ken Mackie, Hui-Chen Lu, Heather B Bradshaw

BBA Adv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Edward M Vital, Joan T Merrill, Eric F Morand, Richard A Furie, Ian N Bruce, Gabriel Abreu

Ann Rheum Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom-based clusters of hospitalized patients with severe acute respiratory illness by SARS-CoV-2 in Brazil.
Letícia Martins Raposo, Gabriel Ferreira Diaz Abreu, Felipe Borges de Medeiros Cardoso, André Thiago Jonathas Alves, Paulo Tadeu Cardozo Ribeiro Rosa

J Infect Public Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin A nephropathy in paediatrics: An up-to-date.
Rafaela Moreira Paranhos, Gabriel Augusto De Souza Figueiredo, Gabriel Ramos De Abreu, Guilherme Costa Ferreira, Giulio Gori Fonseca

Nephrology (Carlton)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumab.
Vibeke Strand, Sean O'Quinn, Richard A Furie, Eric F Morand, Kenneth C Kalunian, Gabriel Abreu

Lancet Rheumatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis